Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 426-620-5 | CAS number: 619297-89-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Additional toxicological data
Administrative data
- Endpoint:
- additional toxicological information
- Type of information:
- other:
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Report based on results from GLP studies according to OECD and/or EU guidelines
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 998
- Report date:
- 1998
Materials and methods
- Type of study / information:
- not applicable
- Principles of method if other than guideline:
- Summary and evaluation fo the toxicity data for AE 141158 gained from several base set studies.
- GLP compliance:
- yes
Test material
- Reference substance name:
- -
- EC Number:
- 426-620-5
- EC Name:
- -
- Cas Number:
- 619297-89-1
- Molecular formula:
- C7H4IO5S.K
- IUPAC Name:
- potassium 2-carboxy-5-iodobenzene-1-sulfonate
- Details on test material:
- The test substance which is a light apricot colored powder was tested in all toxicological experiments at a purity of 99.2 % except in the acute
oral study where a technical substance of 96.7 % was administered.
Constituent 1
Results and discussion
Any other information on results incl. tables
Acute oral toxicity AE F 141 158 was applied by gavage at a dose level of 2000 mg/kg bw to five male Wistar rats. Five female rats per group received dose levels of 1600; 2000 or 2500 mg/kg b w. There were no deaths in males. Mortalities in females were 0/5; 3/5 and 3/5 from 1600 up to 2500 mg/kg bw. Clinical symptoms at 2000 mg/kg bw and 2500 mg/kg bw were comprised of stilted gait, squatting posture, swollen abdomen and irregular respiration. Some of the females showed decreased spontaneous activity, stupor, bristled coat, sunken flanks, uncoordinated gait, prone position and trembling. Clinical symptoms were seen during the first two days after application. During macroscopic examination of the deceased females light discoloration of the liver, petechial bleedings and detachment of the stomach mucosa, yellowish or reddish mucous and detachment of the mucosa in the intestine, light discoloration of the kidneys and red discoloration of lungs was recorded. Body weight development was not affected by treatment and the animals did not show macroscopically visible changes when they were killed and examined at the end of the 14 day observation period. The LDso for females was calculated 2179 mg/kg bw. Males were less sensitive. (Jensch1996). Acute dermal toxicity AE F 141 158 moistened with deionized water was applied to the shaved dorsal skin of five male and five female Wistar rats at a dose of 2000 mg/kg b w. There were no mortalities or symptoms of intoxication. The LD^ dermal was considered to be above 2000 mg/kg bw. No indications for local irritating effects could be found. Treatment did not affect body weight gain and there were no macroscopical changes when animals were killed at the end of the post-treatment observation period after 14 days (Jensch1997). Primary skin irritation in the rabbit Primary skin irritation of AE F 141 158 was tested in 3 female New Zealand White rabbits in a test protocol according to EEC Guideline B.4. of Directive 92/69/EEC. The test substance was moistened with 0.3 ml deionized water. There were no signs of irritation or systemic intoxication at any evaluation time (Kreiling 1997a). Primary eye irritation in the rabbit Primary eye irritating properties of AE F 141 158 were tested in three female New Zealand White rabbits in a test protocol according to EEC Guideline B.5. of Directive 92/69/EEC. One hour up to three days after administration the treated eyes of the first animal showed intense erythema (grade 3) and chemosis (grade 3). The iris was reddened. Diffuse corneal areas were recorded on day one and two and clear colorless discharge was noted. Effects were reversible within 7 days. The other two animals showed intense erythema (grade 3) and chemosis (grade 3). Also in this case the iris was reddened, diffuse corneal areas were recorded and clear colorless discharge was noted. The bottom of the treated eyes showed cloudy white crystalline discolorations. Due to the nature of the irritation findings, especially of the discoloration at the bottom of the eye, the effects were considered irreversible and the two rabbits were killed for animal welfare reasons one day after application. Based on the severe eye irritating properties as observed in the second and third animal the substance should be classified as Xi: Irritant and labelled with R 41: Risk of serious damage to the eyes (Kreiling 1997b). Sensitization testing in the guinea pig AE F141 158 was tested for sensitizing properties in a Magnusson & Kligman test in a group of 10 female Pirbright White guinea pigs. Five animals were used as solvent controls. Intradermal induction was carried out with a concentration of 5 % AE F141 158 dissolved in deionized water, whereas a 25 % preparation was used for dermal induction and challenge. During treatment no indications of systemic toxicity or effects on body weight development were found.No signs of irritation were seen after challenge treatment. Based on the results of this assay, AE F 141 158 has no dermally sensitizing potential under the conditions of the maximization test (Bury 1997). Genotoxicity AE F 141 158 was not mutagenic in a test according to Ames on Samonella typhimurium TA 100, TA 1535, TA 1537, TA 98 and on E. coli WP 2uvrA in the presence or absence of a metabolizing system (rat liver S-9 mix, Aroclor 1254 induced). Test concentrations ranged from 4 ug up to 5000 ug per plate. No indication of cytotoxicity was seen (Miiller 1998a). The substance did not induce chromosomal aberration in an V 79 Chinese Hamster Cell system in vitro with or without S-9 mix. Test concentrations in DMSO ranged from 375 ug/ml up to 3200 ug/ml (without S-9 mix) and from 750 ug/ml up to 3661.7 ug/ml (with S-9 mix). Evaluation was done at 20 and 28 hrs after exposure. Cytotoxicity was seen only without S-9 mix at 2500 ug/ml and at 3200 ug/ml. AE F 141 158 did not induce significant increases in chromosome aberration in the presence or absence of a metabolic activation system (Miiller 1998b). Oral 28 day study AE F141 158 dissolved in deionized water was applied via gavage to groups of five male and five female Wistar rats at dose levels of 0 (solvent control), 62.5; 250 or 1000 mg/kg bw for a period of 28 days in a protocol according to EEC guideline B.7 of Directive 96/54. In addition to regular health checks, clinical examinations, recording of body weight, food and water consumption detailed clinical observations under open field conditions were performed weekly. At the end of the administration period assessment of sensory function, motor activity, grip strength and landing food spread tests were carried out. Urinalysis was performed towards the end of the treatment period. Blood samples for hematology and clinical chemistry were taken immediately prior to necropsy. Major organs were processed and checked for microscopically visible changes. There were no mortalities, clincal symptoms or substance-related findings during hematology, clinical chemistry, urinalysis or neurotoxicological screening program. No compound-related macroscopical findings were seen during necropsy. The only doserelated finding in the histopathological investigation was hypertrophy of mucous neck cells of the fundic mucous membrane of the stomach at 250 and 1000 mg/kg bw. No such effect could be seen at 62.5 mg/kg bw. This phenomenon was not interpreted as adverse effect, since it did not involve cell damage or necrosis and no cell hyperplasia could be found. It was therefore regarded as a protective effect for the mucous membrane. Based on the above the NOAEL for the 28 day administration of AE F141 158 to male and female Wistar rats was 1000 mg/kg bw. |
Applicant's summary and conclusion
- Conclusions:
- AE F 141 158 was slightly toxic to female rats in acute oral experiments. Males were
less sensitive. No systemic or local hazard potential was identified during testing of the
dermal LDgo. This corresponds well to the skin tests where the compound proved
neither irritating to the rabbit skin nor dermally sensitizing to guinea pigs. A particular
hazard potential was identified in the eye irritation test. The substance caused severe
irritations and irreversible discolorations and should be classified as Xi: Irritant and
labelled with R 41: Risk of serious damage to the eyes. Safety measures and advices to
avoid eye contact are considered necessary.
AE F 141 158 did not show genotoxic properties during in vitro testing for mutagenic
properties in bacterial cells and for chromosomal aberration in V 79 cells. No adverse
effects were found in a 28 day study in rats at the high dose of 1000 mg/kg body
weight.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.